Goldstein Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
Goldstein Advisors's MRK Position: Q2 2026 in Review
Goldstein Advisors increased its Merck (MRK) stake by 21% in Q2 2026, buying an estimated $88.7K and bringing the position to 4,434 shares worth $570K. The position accounts for 0.05% of the portfolio, ranked #120.
Goldstein Advisors first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Goldstein Advisors held 4,434 shares of Merck worth $570K as of Q2 2026.
- Goldstein Advisors bought 758 Merck shares in Q2 2026, an estimated $88.7K.
- Merck made up 0.05% of Goldstein Advisors's portfolio in Q2 2026, its #120 holding.
- Goldstein Advisors first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Goldstein Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.